Validation of automatically measured monophasic action potential recordings

Computers in Biology and Medicine
Jong-Min LeeYou-Ho Kim

Abstract

This study devised an automatic monophasic action potential (MAP) measurement program, and compared the computer-measured MAP durations with those measured manually by two independent observers in order to facilitate the analysis of MAP data obtained during a clinical electrophysiology study. The results were compared at various cycle lengths and during pharmacologic or physiologic interventions. This program identified the onset, plateau, and baseline accurately using the MAP data. The automatically measured MAP durations at the 90% repolarization level (MAPd) strongly correlated with those measured manually (r = 0.99). The MAPd shortened in parallel as the pacing cycle length was progressively shortened from 800 to 600, 400 and 300 ms.

References

Nov 1, 1992·Pacing and Clinical Electrophysiology : PACE·H CalkinsF Morady
Feb 1, 1990·Pacing and Clinical Electrophysiology : PACE·N KanaanA Kadish
May 1, 1991·Progress in Cardiovascular Diseases·M R Franz
Oct 1, 1990·Journal of the American College of Cardiology·M R FranzM M Scheinman
Jun 1, 1988·Journal of the American College of Cardiology·S Kaseda, D P Zipes
Sep 1, 1995·Pacing and Clinical Electrophysiology : PACE·M R FranzM Zabel
Mar 1, 1996·Pacing and Clinical Electrophysiology : PACE·S YuanC Blomström-Lundqvist
Feb 1, 1996·Journal of Cardiovascular Electrophysiology·P T Sager, M Behboodikhah
Sep 1, 1996·Journal of Cardiovascular Electrophysiology·T Satoh, D P Zipes
Apr 16, 1998·Medical & Biological Engineering & Computing·D R DickensonG N Beatch

❮ Previous
Next ❯

Citations

Dec 20, 2005·Pacing and Clinical Electrophysiology : PACE·Gi-Byoung NamJong-Min Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.